A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease

NCT07010926 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn&Amp;#39;s
Crohn&Amp;#39;s Disease (CD)

Interventions

BIOLOGICAL: L2-01 adipose-derived mesenchymal stem cells (MSC)
OTHER: Placebo saline solution

Sponsor

L2 Bio, LLC

Collaborators

[object Object]
[object Object]